搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
14 天
又一款ADC药物获批上市
除了第一三共的Dato-DX外,目前还有两款针对TROP-2的ADC药物获批。一个是吉利德公司的Trodelvy,其在乳腺癌治疗领域展现出了显著的潜力。
来自MSN
1 个月
科伦博泰芦康沙妥珠单抗国内获批上市系首个获得完全批准上市的 ...
此前,由吉利德科学(Gilead Sciences)研发的注射用戈沙妥珠单抗(商品名:拓达维,Trodelvy)是全球首个获批用于治疗三阴乳腺癌的TROP2 ADC。2022年6月 ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
Trump bans trans athletes
To accept parcels from China
Blocks citizenship order
Eggs worth $40K stolen
Judge tosses last charge
Parked Delta plane struck
Fox News hires Lara Trump
Thousands protest policies
FBI agents won't lose jobs
Offers buyouts to workforce
Alex Jones bankruptcy case
Strikes deal on migrants
Synagogue shooting plea
Renowned saxophonist dies
Matt Kuchar's father dies
All 67 bodies recovered
Winter weather warnings
When is the next full moon?
Confirmed as HUD secretary
To stencil 'Choose Love'
Ohio warehouse shooting
Blake Lively sued again
Abuse scandal settlement
Second strain in dairy cattle
Lose trademark ownership
World War II pilot dies
Neil Jacobs to lead NOAA
Hyde announces retirement
US trade deficit widens
US private payrolls rise
反馈